Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bös

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Der Nervenarzt|September 28, 2007
[Anticonvulsant treatment with zonisamide added to topiramate. A preliminary treatment analysis in 19 patients]M Bös, J Bauer
Pharmazie in Unserer Zeit|March 1, 1984
[Sydnones and sydnonimines. Chemistry and pharmacology]M Bös, W Fleischhacker
Der Nervenarzt|January 20, 2007
[Cerebellar syndromes in Langerhans' cell histiocytosis]M Bös, C Grothe, H Urbach, et al.
Der Nervenarzt|July 15, 2010
[Evaluation of folate substitution in women with epilepsy. Determination of erythrocyte folic acid concentrations]J Bauer, M Bös, J Rück, et al.
British Journal of Pharmacology|January 12, 1999
Involvement of 5-HT6 receptors in nigro-striatal function in rodentsA Bourson, F G Boess, M Bös, et al.
Der Nervenarzt|July 4, 2001
[Cerebellar syndrome, exophthalmos and secondary hypogonadism in Erdheim-Chester disease]C Grothe, H Urbach, M Bös, et al.
Annals of the New York Academy of Sciences|February 3, 1999
The putative 5-ht6 receptor: localization and functionA J Sleight, F G Boess, M Bös, et al.
Archiv Der Pharmazie|July 1, 1995
Resolution, EPC-syntheses, absolute stereochemistry, and pharmacology of the (S)-(+)- and (R)-(-)-isomers of the MAO-A inhibitor tetrindole hydrochlorideM Bös, R Canesso, R Kettler, et al.
Mutagenesis|August 26, 1998
Suppression of mutagenic activity of a series of 5HT2c receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assayS Albertini, M Bös, E Gocke, et al.
Molecular Pharmacology|March 1, 1990
Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-AA M Cesura, M Bös, M D Galva, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Der Nervenarzt|September 28, 2007
[Anticonvulsant treatment with zonisamide added to topiramate. A preliminary treatment analysis in 19 patients]M Bös, J Bauer
Pharmazie in Unserer Zeit|March 1, 1984
[Sydnones and sydnonimines. Chemistry and pharmacology]M Bös, W Fleischhacker
Der Nervenarzt|January 20, 2007
[Cerebellar syndromes in Langerhans' cell histiocytosis]M Bös, C Grothe, H Urbach, et al.
Der Nervenarzt|July 15, 2010
[Evaluation of folate substitution in women with epilepsy. Determination of erythrocyte folic acid concentrations]J Bauer, M Bös, J Rück, et al.
British Journal of Pharmacology|January 12, 1999
Involvement of 5-HT6 receptors in nigro-striatal function in rodentsA Bourson, F G Boess, M Bös, et al.
Der Nervenarzt|July 4, 2001
[Cerebellar syndrome, exophthalmos and secondary hypogonadism in Erdheim-Chester disease]C Grothe, H Urbach, M Bös, et al.
Annals of the New York Academy of Sciences|February 3, 1999
The putative 5-ht6 receptor: localization and functionA J Sleight, F G Boess, M Bös, et al.
Archiv Der Pharmazie|July 1, 1995
Resolution, EPC-syntheses, absolute stereochemistry, and pharmacology of the (S)-(+)- and (R)-(-)-isomers of the MAO-A inhibitor tetrindole hydrochlorideM Bös, R Canesso, R Kettler, et al.
Mutagenesis|August 26, 1998
Suppression of mutagenic activity of a series of 5HT2c receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assayS Albertini, M Bös, E Gocke, et al.
Molecular Pharmacology|March 1, 1990
Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-AA M Cesura, M Bös, M D Galva, et al.
Pageof 2